Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Follow-up of Ragweed MATA MPL Efficacy in Seasonal Allergic Rhinitis
NCT00325338Phase 2Completed
- Sponsor
- Allergy Therapeutics PLC
- Start
- May 2006
- Modality
- Allergy Immunotherapy
- Countries
- 1
01
Overview
A Phase 2 trial of Pollinex Quattro Ragweed in seasonal allergic rhinitis (SAR), sponsored by Allergy Therapeutics PLC. Started May 2006; status: completed.
02
Drugs
Pollinex Quattro Ragweed
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT00325338.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00325338.